S. Iio

发表

Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C

N. Hiramatsu, M. Shigekawa, H. Hikita, 2016, PloS one.

Baseline quasispecies selection and novel mutations contribute to emerging resistance-associated substitutions in hepatitis C virus after direct-acting antiviral treatment

Y. Imai, H. Suemizu, N. Hiramatsu, 2017, Scientific reports.

Comparison of atezolizumab plus bevacizumab and lenvatinib in terms of efficacy and safety as primary systemic chemotherapy for hepatocellular carcinoma

Y. Imai, K. Ohkawa, T. Kodama, 2022, Hepatology research : the official journal of the Japan Society of Hepatology.

Influence of transfusion‐transmitted virus infection on the clinical features and response to interferon therapy in Japanese patients with chronic hepatitis C

N. Hayashi, A. Kasahara, H. Fusamoto, 1999, Journal of viral hepatitis.

GBV‐C/HGV infection in chronic hepatitis C patients: Its effect on clinical features and interferon therapy

N. Hayashi, A. Kasahara, N. Hiramatsu, 1998, Journal of medical virology.

Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection

Y. Imai, N. Hayashi, A. Kasahara, 2012, Journal of Gastroenterology.

Ultra‐deep sequencing analysis of resistance‐associated variants during retreatment with simeprevir‐based triple therapy after failure of telaprevir‐based triple therapy in patients with genotype 1 hepatitis C virus infection

Y. Imai, N. Hayashi, N. Hiramatsu, 2017, Hepatology research : the official journal of the Japan Society of Hepatology.

Therapeutic efficacy of lenvatinib in hepatocellular carcinoma patients with portal hypertension

K. Ohkawa, T. Kodama, Ryoko Yamada, 2020, Hepatology research : the official journal of the Japan Society of Hepatology.

Endogenous nitric oxide attenuates ethanol‐induced perturbation of hepatic circulation in the isolated perfused rat liver

H. Fusamoto, T. Kamada, Y. Takei, 1994, Hepatology.

Significance of serum soluble Fas antigen level in chronic hepatitis C patients treated with interferon: Relationship to the therapeutic response

N. Hayashi, A. Kasahara, N. Hiramatsu, 2001, Journal of gastroenterology and hepatology.

Serum levels of soluble Fas antigen in chronic hepatitis C patients

N. Hayashi, A. Kasahara, N. Hiramatsu, 1998, Journal of Hepatology.

Impact of alpha-fetoprotein on hepatocellular carcinoma development during entecavir treatment of chronic hepatitis B virus infection

Y. Imai, N. Hayashi, A. Kasahara, 2015, Journal of Gastroenterology.

Dynamics of regulatory T cells and plasmacytoid dendritic cells as immune markers for virological response in pegylated interferon-α and ribavirin therapy for chronic hepatitis C patients

N. Hayashi, A. Kasahara, N. Hiramatsu, 2012, Journal of Gastroenterology.

Pretreatment with antibiotics is associated with reduced therapeutic response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma

N. Hiramatsu, K. Imanaka, K. Ohkawa, 2023, PloS one.

Serum levels of soluble Fas antigen in chronic hepatitis C patients

N. Hayashi, A. Kasahara, N. Hiramatsu, 1998, Journal of hepatology.

Acute compartment syndrome as the initial manifestation of chronic-phase chronic myeloid leukemia: a case report and review of the literature

H. Narahara, Tomohisa Machida, S. Kawata, 2016, Journal of Medical Case Reports.

Pre-existing minor variants with NS5A L31M/V-Y93H double substitution are closely linked to virologic failure with asunaprevir plus daclatasvir treatment for genotype 1b hepatitis C virus infection

Y. Imai, T. Kodama, Ryoko Yamada, 2020, PloS one.

Prognostic impact of worsening of esophageal varices after balloon‐occluded retrograde transvenous obliteration

T. Kodama, Ryoko Yamada, H. Hikita, 2022, Journal of gastroenterology and hepatology.

Release of Calcitonin Gene‐Related Peptide‐Like Immunoreactive Substance from Neuromuscular Junction by Nerve Excitation and Its Action on Striated Muscle

Y. Imai, S. Uchida, H. Yoshida, 1990, Journal of neurochemistry.

Clinical course of hepatitis C virus‐positive patients with decompensated liver cirrhosis in the era of direct‐acting antiviral treatment

N. Hiramatsu, T. Kodama, Ryoko Yamada, 2021, Hepatology research : the official journal of the Japan Society of Hepatology.

Reducing Peg-IFN doses causes later virologic response or no response in HCV genotype 1 patients treated with Peg-IFN alfa-2b plus ribavirin

Y. Imai, N. Hayashi, A. Kasahara, 2012, Journal of Gastroenterology.

Using early viral kinetics to predict antiviral outcome in response-guided pegylated interferon plus ribavirin therapy among patients with hepatitis C virus genotype 1

Y. Imai, N. Hayashi, A. Kasahara, 2014, Journal of Gastroenterology.

Role of Fas ligand in apoptosis induced by hepatitis C virus infection.

N. Hayashi, A. Kasahara, H. Fusamoto, 1994, Biochemical and biophysical research communications.

Effect of sofosbuvir and velpatasvir therapy on clinical outcome in hepatitis C virus patients with decompensated cirrhosis

N. Hiramatsu, K. Imanaka, K. Ohkawa, 2022, Hepatology research : the official journal of the Japan Society of Hepatology.

Binding cells of125I-iodoamphetamine in rat liver

N. Hayashi, H. Fusamoto, T. Kamada, 1997, Annals of nuclear medicine.

IgE Plasma Cell Leukemia Harboring t(11;14) and 1q Amplification

K. Oka, S. Iio, S. Ueda, 2023, Case reports in hematology.

Impact of branched‐chain amino acid supplementation on survival in patients with advanced hepatocellular carcinoma treated with sorafenib: A multicenter retrospective cohort study

Y. Imai, S. Marubashi, N. Hayashi, 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

Neuroendocrine tumor of the minor duodenal papilla with lymph node metastasis: a case report and literature review

H. Ota, M. Fukunaga, S. Iio, 2023, International Cancer Conference Journal.

Impact of alpha-fetoprotein on hepatocellular carcinoma development during entecavir treatment of chronic hepatitis B virus infection

Y. Imai, N. Hayashi, A. Kasahara, 2015, Journal of Gastroenterology.

Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter prospective observational study

N. Hiramatsu, K. Imanaka, K. Ohkawa, 2024, PloS one.